1. Aortic hemodynamic parameters as predictors of incident or deteriorating hypertension during carfilzomib therapy in patients with relapsed multiple myeloma. (14th October 2021) Authors: Laina, A; Georgiopoulos, G; Makris, N; Gavriatopoulou, M; Papanagnou, E; Eleutherakis-Papaiakovou, E; Fotiou, D; Dialoupi, I; Migkou, M; Roussou, M; Terpos, E; Trougakos, I; Dimopoulos, M A; Kastritis, E; Stamatelopoulos, K Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. B08: A THIRD BNT162B2 DOSE INDUCES ANTIBODY RESPONSES AGAINST SARS-COV-2 EVEN IN PREVIOUSLY NON-RESPONDERS WITH MULTIPLE MYELOMA. (5th April 2022) Authors: Terpos, E; Gavriatopoulou, M; Ntanasis-Stathopoulos, I; Briasoulis, A; Gumeni, S; Malandrakis, P; Papanagnou, E-D; Migkou, M; Kanellias, N; Kastritis, E; Trougakos, I P; Dimopoulos, M A Journal: HemaSphere Issue: Volume 6(2022)Supplement 2 Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Global deterioration of cardiovascular mechanics by carfilzomib treatment is associated with proteasome activity in patients with relapsed multiple myeloma. (14th October 2021) Authors: Makris, N; Laina, A; Georgiopoulos, G; Gavriatopoulou, M; Papanagnou, E.D; Eleutherakis-Papaiakovou, E; Fotiou, D; Dialoupi, I; Migkou, M; Roussou, M; Terpos, E; Trougakos, I.P; Dimopoulos, M A; Kastritis, E; Stamatelopoulos, K Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Mineralocorticoid receptor signaling is implicated in carfilzomib-induced increase in blood pressure. (14th October 2021) Authors: Efentakis, P; Lamprou, S; Makridakis, M; Barla, I; Nikolaou, P.-E; Christodoulou, A; Dimitriou, C; Kastritis, E; Gakiopoulou, C; Gikas, E; Vlachou, A; Thomaidis, N; Dimopoulos, M A; Terpos, E; Andreadou, I Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P1577Cancer therapeutic related vaso- and cardio-toxicity in patients receiving chemotherapy for breast cancer. (28th August 2018) Authors: Anastasiou, M; Oikonomou, E; Zagouri, F; Siasos, G; Antonopoulos, A S; Tsalamandris, S; Papakostas, P; Psaltopoulou, T; Bamias, A; Dimopoulos, M A; Tousoulis, D Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P4787Investigating the molecular mechanisms of carfilzomib-induced cardiotoxicity and the emerging role of metformin as a prophylactic therapy. (28th August 2018) Authors: Kremastiotis, G; Efentakis, P; Varela, A; Davos, C H; Papanagnou, E.-D; Trougakos, I P; Kastritis, E; Kanaki, Z; Iliodromitis, E K; Klinakis, A; Dimopoulos, M A; Terpos, E; Andreadou, I Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Peripheral vascular involvement in transthyretin cardiac amyloidosis. A comparative analysis with AL amyloidosis. (14th October 2021) Authors: Stamatelopoulos, K; Delialis, D; Bampatsias, D; Tselegkidi, M E; Petropoulos, I; Theodorakakou, F; Gavriatopoulou, M; Patras, R; Pamboucas, C; Kanakakis, J; Ikonomidis, I; Terpos, E; Trougakos, I P; Dimopoulos, M A; Kastritis, E Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SARS-CoV-2 is associated withabnormal biomarkers of oxidative stress, and endothelial function linked with cardiovascular dysfunction four months after the infection. (3rd October 2022) Authors: Ikonomidis, I; Kountouri, A; Mitrakou, A; Thymis, J; Katogiannis, K; Korakas, E; Varlamos, C; Bamias, A; Thomas, K; Andreadou, I; Tsoumani, M; Kavatha, D; Antoniadou, A; Dimopoulos, M A; Lambadiari, V Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Sustained vasodilation after cold pressor test is an independent predictor of poor survival in primary AL amyloidosis. (3rd October 2022) Authors: Patras, R; Georgiopoulos, G; Petropoulos, I; Theodorakakou, F; Delialis, D; Angelidakis, L; Gavriatopoulou, M; Dimopoulou, M A; Sianis, A; Maneta, E; Neofytou, O; Terpos, E; Dimopoulos, M A; Kastritis, E; Stamatelopoulos, K Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Understanding the molecular mosaic of cardiotoxicity of light chains in plasma cell dyscrasias and cardiac light chain amyloidosis with the use of patient derived full-length light chains. (3rd October 2022) Authors: Nikolaou, P E; Georgoulis, A; Liacos, C; Makridakis, M; Efentakis, P; Baltatzis, G; Mavroidi, B; Pelecanou, M; Vlachou, A; Terpos, E; Vorgias, C E; Dimopoulos, M A; Kastritis, E; Andreadou, I Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗